Vertex Reports Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Vertex Pharma (VRTX) Tops Q3 EPS by 5c; bumps guidance
November 6, 2023 4:02 PM ESTVertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $3.97, $0.05 better than the analyst estimate of $3.92. Revenue for the quarter came in at $2.48 billion versus the consensus estimate of $2.5 billion.
GUIDANCE:
Vertex Pharma sees FY2023 revenue of $9.85 billion, versus prior guidance of... More
